Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-16 12:07 pm Purchase | 2020-12-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC | EcoR1 Capital LLC | 3,092,218 8.700% | 450,000 (+17.03%) | Filing History |
| 2021-02-16 12:05 pm Sale | 2020-12-31 | 13G | Neoleukin Therapeutics, Inc. NLTX | EcoR1 Capital LLC | 156,135 7.500% | -39,659 (-20.26%) | Filing History |
| 2021-02-16 12:02 pm Purchase | 2020-12-31 | 13G | Morphic Holding, Inc. MORF | EcoR1 Capital LLC | 2,839,884 9.100% | 685,039 (+31.79%) | Filing History |
| 2021-02-16 12:00 pm Sale | 2020-12-31 | 13G | Kura Oncology, Inc. KURA | EcoR1 Capital LLC | 1,773,037 2.700% | -2,468,916 (-58.20%) | Filing History |
| 2021-02-16 11:58 am Sale | 2020-12-31 | 13G | Geron Corporation GERN | EcoR1 Capital LLC | 28,555,310 8.900% | -290,844 (-1.01%) | Filing History |
| 2021-02-16 11:56 am Purchase | 2020-12-31 | 13G | Atreca, Inc. BCEL | EcoR1 Capital LLC | 2,426,685 8.100% | 945,274 (+63.81%) | Filing History |
| 2021-02-16 11:54 am Purchase | 2020-12-31 | 13G | Akouos, Inc. AKUS | EcoR1 Capital LLC | 1,975,984 5.700% | 1,975,984 (New Position) | Filing History |
| 2021-02-16 09:49 am Unchanged | 2020-12-31 | 13G | Savara Inc. SVRA | EcoR1 Capital LLC | 3,040,540 5.300% | 0 (Unchanged) | Filing History |
| 2021-02-12 5:48 pm Sale | 2020-12-31 | 13G | Savara Inc. SVRA | EcoR1 Capital LLC | 3,040,540 5.300% | -1,432,664 (-32.03%) | Filing History |
| 2021-02-12 5:33 pm Sale | 2020-12-31 | 13G | X4 Pharmaceuticals, Inc. XFOR | EcoR1 Capital LLC | 600,000 3.600% | -415,400 (-40.91%) | Filing History |
| 2021-02-12 5:23 pm Sale | 2020-12-31 | 13G | Sutro Biopharma, Inc. STRO | EcoR1 Capital LLC | 93,416 0.200% | -2,235,076 (-95.99%) | Filing History |
| 2021-02-12 5:19 pm Sale | 2020-12-31 | 13G | Cartesian Therapeutics, Inc. RNAC | EcoR1 Capital LLC | 76,628 2.100% | -153,257 (-66.67%) | Filing History |
| 2021-02-12 4:15 pm Purchase | 2020-12-31 | 13G | Regulus Therapeutics Inc. RGLS | EcoR1 Capital LLC | 365,008 5.400% | 132,744 (+57.15%) | Filing History |
| 2021-02-12 4:06 pm Sale | 2020-12-31 | 13G | PREVAIL THERAPEUTICS INC PRVL | EcoR1 Capital LLC | 0 0.000% | -2,248,306 (Position Closed) | Filing History |
| 2021-02-12 3:58 pm Sale | 2021-12-31 | 13G | Puma Biotechnology, Inc. PBYI | EcoR1 Capital LLC | 0 0.000% | -2,536,156 (Position Closed) | Filing History |
| 2021-02-12 3:52 pm Sale | 2020-12-31 | 13G | Merus N.V. MRUS | EcoR1 Capital LLC | 0 0.000% | -1,906,861 (Position Closed) | Filing History |
| 2021-02-12 3:42 pm Sale | 2020-12-31 | 13G | GlycoMimetics, Inc. GLYC | EcoR1 Capital LLC | 0 0.000% | -2,909,800 (Position Closed) | Filing History |
| 2021-02-12 3:36 pm Sale | 2020-12-31 | 13G | Dicerna Pharmaceuticals, Inc. DRNA | EcoR1 Capital LLC | 0 0.000% | -3,627,597 (Position Closed) | Filing History |
| 2021-02-12 3:27 pm Unchanged | 2020-12-31 | 13G | Chiasma, Inc. CHMA | EcoR1 Capital LLC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2021-02-12 3:18 pm Sale | 2020-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS | EcoR1 Capital LLC | 1,509,812 3.500% | -577,500 (-27.67%) | Filing History |